Qingdao Shengshi Zhiyang Import and Export Co., Ltd.
 
 
CJC-1295 without DAC Mod GRF 1-29 Growth Hormone Releasing Research Peptide
  • Brand:Shengshizhiyang
  • Model:1*1
  • Purity:99%
  • Cas:863288-34-0
  • Createtime: 2026-07-08
  • Updatetime: 2026-06-30
Product Details
One box 10vials
useage High purity peptide for GH release, muscle anabolism and metabolic endocrine lab research
deliveryInfo
appearance White lyophilized powder
aliasen
supplyCapacity 100G/Day
harbor Hong Kong
minorder 1G
Payment method Alibaba, PayPal, USDT, bank card, Western Union remittance
Delivery date 10 days
Whatsapp +86 155 1138 8892

Name: CJC-1295 without DAC

Alias: Mod GRF 1-29
CAS Registry number: 863288-34-0
Sequence:
H-Tyr-D-Ala-Asp-Ala-Ile-Phe-Thr-Asn-Ser-Tyr-Arg-Lys-Val-Leu-Gly-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Met-Ser-Arg-NH?
Molecular Formula: C???H???N??O??S
Molecular Weight: 3367.98 Da
Purity: ≥99% (by HPLC)
Appearance: White lyophilized powder
Packing: 10 vials/box (10mg total per vial)
Product Group: Growth hormone releasing hormone analog peptide

Storage Conditions: Store at -20℃ in a dry, dark place; avoid repeated freeze-thaw cycles.


Brief Introduction:

CJC-1295 without DAC, also known as Mod GRF 1-29, is a synthetic GHRH analog exclusively for laboratory research. It removes the DAC lipid modification group, with shorter half-life and rapid metabolic clearance compared with DAC-conjugated CJC-1295. It specifically binds to pituitary GHRH receptors to stimulate steady endogenous growth hormone release, and forms prominent synergistic GH-boosting effects when combined with GHRP-2 or GHRP-6. It participates in lean muscle growth, fat catabolism and endocrine aging regulation, widely applied in endocrinology, body composition and metabolic physiology research.


Main Research Applications:
Growth hormone releasing endocrine research: Used in cell and animal models to study GHRH receptor activation and rhythmic GH secretion regulation.
Muscle anabolism & fat metabolism research: Suitable for exploring lean mass accumulation and adipose tissue lipolysis related pathways.
Peptide synergy mechanism research: Applied to investigate combined GH elevation effects with GHRP-2, GHRP-6 and other secretagogue peptides.
Metabolic aging research: For comparative analysis of age-related growth hormone decline and metabolic disorder intervention.
Hormone balance research: Study the regulatory impact on IGF-1, insulin and body energy metabolism.


Note:

This product is for laboratory research use only. It is not intended for human or animal therapeutic use, clinical trials, or any form of in vivo administration without prior ethical approval and regulatory authorization.


Contact
Phone:+852 5426 4167
Tel:--
Whatsapp:852 5426 4167